2CUREX Share Price Performance
SEK 1.68
1.11 (196.46%)
Price SEK 1.68
Share PriceSEK 1.68
2cureX AB (publ) Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 1 Fair Values set on narratives written by author
2CUREX Community Narratives
There are no narratives available yet.
Recent 2CUREX News & Updates
2cureX AB (publ) Key Details
Last Reported Earnings
Jun 30, 2024
Next Reporting Earnings
Feb 26, 2026
- Earnings per share (EPS)
- -1.05
- Gross Margin
- -386.18%
- Net Profit Margin
- -1,333.30%
- Debt/Equity Ratio
- 0%
2cureX AB (publ) Competitors
Snowflake Analysis
About 2CUREX
- Founded
- 2006
- Employees
- 14
- CEO
- WebsiteView website
2cureX AB (publ) operates as a medtech company in Europe. The company’s principal product is IndiTreat, an IVD test, which helps to predict cancer patient’s response and resistance to different drugs and select the appropriate treatment. It is also conducting various clinical programs for IndiTreat for colorectal, ovarian, and pancreatic cancers. In addition, the company offers research and consulting services. 2cureX AB (publ) was incorporated in 2006 and is based in Copenhagen, Denmark.
Market Insight
Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading
Danish Market Performance
- 7 Days: -0.06%
- 3 Months: -7.9%
- 1 Year: -34.2%
- Year to Date: -23.0%
The Information Technology sector gained 3.0% while the market remained flat over the last week. Unfortunately though, the market is down 34% over the past year. Earnings are forecast to grow by 4.2% annually. Market details ›